Zebrafish based assays for the assessment of cardiac, visual and gut function — potential safety screens for early drug discovery
Authors:
- Stéphane BerghmansSBStéphane Berghmans
- Paul ButlerPBPaul Butler
- Paul GoldsmithPGPaul Goldsmith
- Gareth WaldronGWGareth Waldron
- Iain GardnerIGIain Gardner
- Zoe GolderZGZoe Golder
- Frances M. RichardsFRFrances M. Richards
- Gillian KimberGKGillian Kimber
- Alan RoachARAlan Roach
- Wendy AldertonWAWendy Alderton
- Angeleen FlemingAFAngeleen Fleming
- 1 July 2008
- journal article
- research article
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 58 (1) , 59-68
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Ocular Adverse Effects Associated with Systemic MedicationsDrugs, 2007
- Genome-Wide Reverse Genetics Framework to Identify Novel Functions of the Vertebrate SecretomePLOS ONE, 2006
- Predictive value of in vitro safety studiesCurrent Opinion in Chemical Biology, 2006
- The zebrafish as a model system for assessing the reinforcing properties of drugs of abuseMethods, 2006
- New models and molecular markers in evaluation of developmental toxicityToxicology and Applied Pharmacology, 2005
- Safety pharmacology: an essential interface of pharmacology and toxicology in the non-clinical assessment of new pharmaceuticalsToxicology Letters, 2004
- 5‐HT4receptors are not involved in the control of small intestinal transit in the fasted conscious ratNeurogastroenterology & Motility, 1996
- Stages of embryonic development of the zebrafishDevelopmental Dynamics, 1995
- Developmental lead exposure inhibits adult rat retinal, but not kidney, Na+,K+-ATPaseToxicology and Applied Pharmacology, 1991
- Changes in duodenal contractility induced by “calcium antagonists” with different modes of actionGeneral Pharmacology: The Vascular System, 1987